In this study, we identified the fusion gene VAPA-Rab31 in a patient with lung adenocarcinoma who did not harbor any known driver mutations in EGFR, KRAS, and ALK. Bronchial epithelial cells that overexpressed the fusion protein demonstrated enhanced proliferation and tumorigenicity. This evidence concerns the gene KRAS and lung adenocarcinoma.